The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 randomized study of SHAPE Gel (SHP-141) in patients with early-stage cutaneous T-cell lymphoma: Interim results.
 
Madeleine Duvic
No Relationships to Disclose
 
Youn H. Kim
Consulting or Advisory Role - Actelion; Celgene; Eisai; Forty Seven; Galderma; Horizon Pharma; Kyowa Hakko Kirin; Millennium; miRagen; Seagen
Research Funding - Eisai (Inst); Innate Pharma (Inst); Kyowa Hakko Kirin (Inst); Merck (Inst); Millennium (Inst); Neumedicines (Inst); Seagen (Inst); Soligenix (Inst); TetraLogic Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Royalty for Chapters in UpToDate
Travel, Accommodations, Expenses - Innate Pharma
 
Nicole R LeBoeuf
No Relationships to Disclose
 
Pierluigi Porcu
No Relationships to Disclose
 
Justin Hastings
No Relationships to Disclose
 
Juri Bassuner
No Relationships to Disclose
 
Laura Sowerby
No Relationships to Disclose
 
Alba Posligua-Alban
No Relationships to Disclose
 
Joan Guitart
No Relationships to Disclose